The present disclosure relates to methods and apparatuses for ultrasonic evaluation of isolated organs.
Organ transplantation remains the only definitive therapeutic solution for many cardiac, renal or hepatic pathologies. However, the number of grafts available for organ transplantation is largely insufficient. Many additional grafts could be available with broader criteria for procurement and preservation. Expanding these criteria requires new means to assess organ integrity and functionality before transplantation.
Once the organ is harvested, the current main approach to evaluation relies on the donor's clinical parameters and a qualitative assessment of the graft by the surgeon based on a few indicators such as visual appearance, color and manual palpation. This evaluation remains highly subjective and does not include any functional parameters. Quantitative evaluation of tissue or vascular properties would allow screening of all available grafts and broaden the number of grafts acceptable for organ transplantation. Two sources of cardiac grafts (currently not exploited) are concerned for an initial assessment of their viability: grafts with a long shelf life (>4-6 h) and grafts harvested after warm ischemia (so-called Maastricht-III grafts).
Moreover, current needs in the field of organ preservation tends to increase the storage time (grafts transported on long distances). The quantitative evaluation of grafts is all the more important to define a conservation threshold adapted to each graft. Finally, the current explosion in the field of regenerative medicine requires tools for anatomical and functional evaluation of organs, especially tissue and vascular properties. Modalities such as MRI or CT are not adapted to graft characterization due to cost and time constraints. Conversely, conventional ultrasound imaging allows a cheap and rapid evaluation, but does not provide quantitative data.
The present specification proposes a new approach to characterize isolated organs by ultrasound, enabling to quantitatively evaluate cardiac or other grafts and if need be, monitor tissue and vascular parameters during organ preservation.
One object of the present disclosure is thus a method for ultrasonic evaluation of an isolated organ from a human or animal received in an organ preservation container made of an ultrasound transparent material, said method comprising:
In embodiments of the above method, one may further use one or several of the following features and any combination thereof:
Several of the above quantitative indexes can be cumulatively used.
In one embodiment, said organ preservation container may be made of an ultrasound transparent and rigid material.
In one embodiment, said organ preservation container may has a geometric shape adapted to perform multidirectional imaging of the isolated organ.
Besides, another object of the present disclosure is an apparatus for ultrasonic evaluation of an isolated organ from a human or animal, comprising:
In embodiments of the above apparatus, one may further use one or several of the following features and any combination thereof:
Other features and advantages will appear from the following description of one embodiment, given by way of non-limiting example, with regard to the drawings.
In the drawings:
The apparatus 1 is for evaluation of an isolated organ 2 from a human or animal, which is meant to be used as a graft.
Isolated organ 2 may be for instance a heart or a kidney or a liver, or another organ.
The apparatus 1 comprises an organ preservation container 3 made of an ultrasound transparent material and adapted to contain said isolated organ 2. The organ preservation container 3 is a rigid box in the illustrated example, but could be any other packaging having rigid, semi-rigid or flexible walls made of a material which is transparent to ultrasounds.
The ultrasound transparent material may be for instance polymethylpentene, e.g. the polymethylpentene sold under trademark TPX®.
In a preferred embodiment, the box comprises peripheral walls made of an ultrasound transparent and rigid material. The peripheral wall has a geometric shape adapted to perform an ultrasound imaging of the whole isolated organ 2 under different directions. In particular, the shape is adapted to perform a multidirectional ultrasound imaging.
As illustrated in
The use of rigid walls permits to avoid mechanical deformation of the organ during ultrasound imaging. This avoids risks of mechanical damage to the organ and improves accuracy of the imaging and measures done through the ultrasound probe, as the organ is in the same state during successive images of the organ (for instance, in the case of a cylindrical container, the images taken in different radial directions and at different heights along the axis of the cylinder).
Isolated organ 2 may be immersed in any graft preservation solution in organ preservation container 3.
Organ preservation container 3 may have fluid connectors 4, 5 for perfusion of isolated organ 2, as known in the art.
Organ preservation container 3 is sealed for conservation of isolated organ 2 and is openable for grafting isolated organ 2.
The apparatus 1 further includes an ultrasound imaging probe 6, which may be of any type known in the art.
Ultrasound imaging probe 6 may for instance include a linear array of ultrasound transducers for 2D ultrasound imaging, or a 2D array of ultrasound transducers for 3D ultrasound imaging. In a variant or in addition, ultrasound imaging probe 6 may include transducers as described for instance in WO2015/114232A1.
The apparatus 1 further includes a holder device 7 for holding ultrasound imaging probe 6 against said organ preservation container 3 to perform ultrasound imaging of isolated organ 2 through said organ preservation container 3.
Some gel may be used to facilitate transmission of ultrasounds between ultrasound imaging probe 6 and organ preservation container 3, as known in the art.
Holder device 7 may be a robotic arm. Said robotic arm may be for instance a 6-axis robotic arm but may be of any other type.
Holder device 7 may be usable to automatically move ultrasound imaging probe 6 during imaging, to obtain successive images of different portions of isolated organ 2 or of the whole isolated organ 2 under different directions as said ultrasound imaging probe 6 is moved.
The apparatus 1 further includes an ultrasound imaging system 8, which can be or include a computer system having at least one display screen 9 and input interfaces (not shown) such as inter alia a keyboard and a mouse for a user.
Ultrasound imaging system 8 communicates with ultrasound imaging probe 6 to obtain at least one ultrasound image of isolated organ 2, in any way which is known in the art.
Ultrasound imaging system 8 may also communicate with holder device 7 and control said holder device to automatically move ultrasound imaging probe 6 by holder device 7 and obtain successive ultrasound images, as explained above.
For instance, as illustrated in
The 2D images are then used to reconstruct an anatomical 3D image of the complete heart.
The automatic scan of the heart as explained above enables to identify, automatically or manually, heart structures such as the septum 2a, the RV 2b and the LV 2c.
In a preferred embodiment, one or several areas of interest are predetermined automatically from the 2D images. Thus, the proposed method advantageously allows an accurate and rapid determination of the areas of interest. The proposed method is thus more reproducible, and does not require experienced users.
In other embodiments, ultrasound imaging probe 6 may include a 2D array of transducers to take 3D images of isolated organ 2. Even in that case, it may be useful to have ultrasound imaging system 8 control holder device 7 and ultrasound imaging probe 6 so as to take several 3D images, corresponding to different points of view or to different areas of isolated organ 3.
Ultrasound imaging system 8 is adapted to determine at least one quantitative index representing viability of isolated organ 2, said quantitative index being calculated from anatomical, tissue or vascular parameters obtained from ultrasound image(s) taken by ultrasound imaging probe 6.
For instance, once predetermined anatomic areas of isolated organ 2 have been automatically identified from said different images of the isolated organ 2 as explained above, said at least one quantitative index may be automatically computed in at least one area of interest among said predetermined anatomic areas. Said at least one area of interest may be manually chosen by an operator or may be automatically chosen or may be predetermined.
Said at least one quantitative index may be determined for several predetermined areas of isolated organ 2 and shown on a parametric map of said isolated organ. When isolated organ 2 is heart, said parametric map may be for instance a bullseye plot (polar plot) as defined by the American Heart Association (AHA), e.g. for showing the distribution of said at least one quantitative index across the left ventricle (for instance segmented according to the 17-Segment Model of the AHA).
Said rheological index may be, for instance, stiffness, propagation speed of shear waves, fractional anisotropy, shear modulus or Young's modulus.
Said quantitative shear wave elastography imaging may be performed on the whole isolated organ or on selected structures.
Two examples will illustrate the relevance of quantitative shear wave elastography imaging to characterize the isolated organs, in the particular case where the isolated organ is the heart.
In example 1, quantitative shear wave elastography imaging was performed on 10 anatomic sites of several porcine hearts, using the apparatus of
The stiffness of these structures was monitored during 20 hours of storage at 4° C. on several hearts and an overall mean stiffness score is calculated (
This example shows that the heart remains flexible during the first 4 hours of storage and then becomes much stiffer. This result is consistent with the maximum storage time of 4 hours used in clinical routine.
Stiffness was also assessed for hearts that suffered before harvesting by warm ischemia, using the apparatus of
Several hearts from both groups were resuscitated at 4 and 20 hours of preservation, and cardiac function was assessed with multifactorial scores.
SWV values correlated strongly with most measured function parameters. The highest correlation cardiac coefficient is found for Rate Pressure Product (RPP), the product between heart rate and systolic blood pressure used to determine the functional index (r{circumflex over ( )}2=0.86), myocardial hardening from palpation performed by two operators (r{circumflex over ( )}2=0.86) and relaxation rate (0.86). The other parameters also correlate well with SWV values, contractility rate which estimates contraction efficiency and end diastolic pressure (EDP) have an R-squared of 0.72 and 0.64.
Other tissue properties can used to characterize the heart:
Regarding the particular case of elastic anisotropy, when isolated organ 2 is fibrous (e.g. a heart), said at least one quantitative index may include a rheological elasticity parameter measured along fibers of isolated organ and a rheological elasticity parameter measured 2 perpendicular to said fibers. The rheological elasticity parameter in that case may be, for instance, the propagation speed of shear waves or any other rheological index mentioned above.
More precisely, such index may in that case be determined using a method for characterizing an anisotropic soft medium comprising at least one portion including fibers and having an outer surface, this method comprising the following steps:
Vascular properties of isolated organ 2 can also be quantified by ultrasound imaging through ultrasound imaging probe 6 and ultrasound imaging system 8. In that case, said isolated organ 2 is perfused in said organ preservation container 3, as known in the art. For this, it is useful to have ultrasound scatterers in the perfusion fluid (for instance red blood cells, ultrasound contrast agents such as microbubbles, nanobubbles, microdroplets or other molecular structures). Vascular flows can be imaged by Doppler imaging (using e.g. Power Doppler or pulsed Doppler) or by ultrasound localization microscopy (ULM) with microbubbles.
Quantitative parameters can thus be determined, such as flow, velocity, flow rate, blood volume, geometrical parameters of the vascular network such as vessel diameter (in particular micro-vessels), density and tortuosity of the vascular network.
Using the apparatus of
Number | Date | Country | Kind |
---|---|---|---|
22305523.7 | Apr 2022 | EP | regional |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2023/059456 | 4/11/2023 | WO |